Abstract
Introduction
The creatine transporter CreaT (SLC6A8) is a member of the superfamily of sodium and chloride coupled transporters for neurotransmitters [1] [2] [3] and organic osmolytes [4, 5] .
The carrier is expressed in diverse tissues including brain, retina, skeletal muscle, heart, and several epithelia [6] [7] [8] [9] . Loss of function mutations of SLC6A8 result in mental retardation with seizures [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] .
The present study explored whether CreaT is regulated by Janus kinase JAK3, which is expressed in a variety of tissues including the brain and participates in the signalling of cytokine receptors [28] [29] [30] [31] [32] [33] . JAK3 confers cell survival and cell proliferation [34] [35] [36] [37] as well as neuroprotection [31] . JAK3 inhibitors have been shown to trigger apoptosis of neoplastic cells [38, 39] , but JAK3 may foster apoptosis of dendritic cells [40] . Cerebral JAK3 expression is up-regulated by irradiation [41] . JAK3 is further involved in the cellular response to hypoxia and ischemia-reperfusion [31, [42] [43] [44] [45] . Down-regulation of JAK3 signaling is a pre-requisite for differentiation of neuronal precursor cells into neurons and oligodendrocytes [46] .
The gain of function mutation A572V JAK3 [17] may cause acute megakaryoplastic leukemia [47, 48] . Replacement of the ATP coordinating lysine by alanine in the catalytic subunit ( K855A JAK3) leads to loss of kinase activity [17] . The pleotropic effects of JAK3 include regulation of transport across the cell membrane [43, 45, [49] [50] [51] [52] [53] [54] including the excitatory amino acid transporters [53] and the Na + /K + ATPase [49] .
In order to test for an effect of JAK3 on CreaT activity, CreaT has been expressed in Xenopus oocytes without and with additional expression of JAK3, 
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Constructs
The cDNA constructs encoding wild-type SLC6A8 (CreaT) [2] , wild-type murine JAK3 (Imagenes, Berlin, Germany), gain of function mutant A568V JAK3 [17] and inactive mutant K851A JAK3 [17] were used for generation of cRNA as described previously [55, 56] .
Electrophysiological recordings in Xenopus oocytes
Xenopus laevis oocytes were prepared as previously described [57] . cRNA encoding CreaT (15 ng), JAK3 wild-type, A568V JAK3 or K851A JAK3 (10 ng) was injected on the same day after the preparation of the Xenopus oocytes. All experiments were performed at room temperature (about 22°C) 4 days after the injection [58] . Twoelectrode voltage-clamp recordings were performed at a holding potential of -60 mV. The data were filtered at 10 Hz and recorded with a Digidata 1322A A/D-D/A converter and Clampex.9.2 software for data acquisition (Axon Instruments). The analysis of the data was performed with Clampfit 9.2 (Axon Instruments) software [59, 60] . The oocytes were maintained at 17°C in ND96-A solution containing: 88.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 5 mM HEPES, 2.5 mM NaOH; Tretracycline (50 mg/l), Ciprofloxacin (1.6 mg/l), Refobacin (100 mg/l) and Theophylin (90 mg/l) as well as sodium pyruvate (5 mM) were added; pH was adjusted to 7.4 by addition of NaOH. The control superfusate (ND96-B) contained 93.5 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 and 5 mM HEPES, pH was adjusted to 7.4 by addition of NaOH (2.5 mM) [61] . The flow rate of the superfusion was 20 ml/min, and a complete exchange of the bath solution was reached within about 10 s [62, 63] .
Statistical analysis
Data are provided as arithmetic means ± SEM; n represents the number of oocytes investigated. All oocyte experiments were repeated with at least three batches of oocytes and in all repetitions qualitatively similar data were obtained. All data were tested for significance by using ANOVA (Tukey test) or t-test, as appropriate. Results with p<0.05 were considered statistically significant.
Results
In order to define the influence of the Janus activated kinase JAK3 on the function of the creatine transporter CreaT (SLC6A8), cRNA encoding SLC6A8 was injected into Xenopus laevis oocytes with or without additional injection of cRNA encoding JAK3. Creatine transport was estimated from creatine induced-current determined by dual electrode voltage clamp. As illustrated in Fig. 1 , no appreciable current was observed in water-injected oocytes indicating that the oocytes did not express significant endogenous electrogenic creatine transport. Creatine exposure of SLC6A8 expressing oocytes was, however, followed by a sizable creatine induced-current. The additional co-expression of wild-type JAK3 was followed by a significant decrease of creatine induced-current in CreaT expressing Xenopus laevis oocytes. Further experiments explored the effect of JAK3 mutants on the creatine induced current in CreaT expressing Xenopus oocytes. To this end the JAK3 mutants were coexpressed in CreaT expressing Xenopus oocytes. As illustrated in Fig. 2 , the effect of JAK3 co-expression was mimicked by co-expression of the gain of function mutant A568V JAK3, but not by co-expression of the inactive K851A JAK3 mutant.
As illustrated in Fig. 3, a 24 hours treatment of Xenopus oocytes expressing both CreaT and wild type JAK3 with the JAK3 inhibitor WHI-P154 (22 µM) was followed by a significant increase of the creatine induced current.
Kinetic analysis was employed to determine whether JAK3 co-expression modifies the maximal creatine induced current or the affinity of the carrier. Xenopus laevis oocytes expressing CreaT (SLC6A8) without or with additional expression of JAK3 were exposed to creatine at concentrations ranging from 3 µM to 3 mM. As shown in Fig. 4 , the creatine induced current was a function of the extracellular creatine concentration. Kinetic analysis revealed that the maximal creatine induced current was significantly (p<0.001) higher in Xenopus laevis oocytes expressing CreaT alone (27.52 ± 1.81 nA, n = 6) than in Xenopus laevis oocytes expressing CreaT together with JAK3 (10.16 ± 0.99 nA, n = 6). The concentration required for half-maximal creatine induced current was highly variable and not significantly different between Xenopus oocytes expressing CreaT alone (466.53 ± 114.64 mM, n = 6) and Xenopus oocytes expressing CreaT together with JAK3 (191.90 ± 70.04 mM, n = 6).
Discussion
The present study discloses a novel function of the Janus activated kinase JAK3, i.e. the down-regulation of the creatine transporter CreaT (SLC6A8). The effect of wild type JAK3 was mimicked by the gain of function mutant A568V JAK3, but not by the kinase dead mutant K851A JAK3. Thus, kinase activity is apparently required for the effect of JAK3 on the creatine transporter. This observation does not necessarily mean that JAK3 directly phosphorylates the carrier. Instead, JAK3 may be effective by regulating other signalling molecules or transporters which indirectly compromise the function of CreaT. JAK3 sensitive signalling includes Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway [64] . In theory, JAK3 could, through this pathway, up-regulate the expression of CreaT regulating signalling molecules. Regulators of CreaT include JAK2 [65] , AMPK [66, 67] , PKC [68] , SPAK [61] , OSR1 [61] , PIKfyve [69] , mTOR [70] , SGK1 [71] , SGK3 [71] , klotho [56] , and peroxisome proliferator-activated receptorgamma co-activator-1alpha (PGC-1α) or beta (PGC-1β) [72] .
The present study did not address the functional significance of JAK3 sensitive CreaT activity. The observation may be, however, related to the JAK3 sensitivity of Na + / K + -ATPase [49] . JAK3 is a powerful inhibitor of Na + /K + ATPase activity thus contributing to the maintenance of cytosolic ATP concentration during energy depletion [49] [49] . Thus, curtailing Na + entry by inhibition of CreaT may serve to mitigate the negative effects of Na + /K + -ATPase inhibition. Opposite to its effect on CreaT, JAK3 up-regulates Na + coupled excitatory amino acid transporters [53] . Those carriers clear excitatory amino acids from the synaptic cleft and thus decrease cation entry following excitation [53] .
As CreaT belongs to a superfamily of several transporters for neurotransmitters [1] [2] [3] and organic osmolytes [4, 5] , the observed CreaT sensitivity to JAK3 may be shared by other carriers of that superfamily. The osmolyte transporters are powerful regulators of cell volume [73] , which may thus be sensitive to JAK3. CreaT is particularly important for the function of the brain [66] . CreaT accomplishes synaptic re-uptake of the neurotransmitter creatine and thus modulates GABAergic and glutamatergic cerebral pathways [66] . Moreover, as creatine biosynthesis consumes 40% of methyl groups and CreaT is regulated by AMPK, creatine is considered a cellular sensor of methylation and energy status [66] . Creatine deficiency disorders including genetic defects of CreaT (SLC6A8) lead to mental retardation, intellectual disability, behavioral disorders, and seizures [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] 66] . Those effects could be explained in part by an imbalance of GABAergic and glutamatergic neurotransmission. Moreover, it is tempting to speculate that the regulation of creatine uptake by JAK3 influences methylation [66] and contributes to the known impact of the kinase on differentiation of neuronal precursor cells into neurons and oligodendrocytes [46] .
In conclusion, JAK3 is a powerful negative regulator of the creatine transporter CreaT (SLC6A8). The effect of JAK3 requires kinase activity and leads to decrease of maximal creatine transport rate. The effect may participate in the regulation of cell survival following energy depletion and neuroexcitability.
